Catalyst Wire Dossier Catalyst Wire Dossier

Neovasculgen

VEGF165 plasmid DNA (pl-VEGF165)
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Neovasculgen, covering 2015-02-02 to 2017-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot [NA]

See pricing